TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment

ClinicalTrials.gov ID: NCT00140309

Public ClinicalTrials.gov record NCT00140309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 26, 2026, 9:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

TBTC Study 27: An Evaluation of the Activity and Tolerability of Moxifloxacin During the First Two Months of Treatment for Pulmonary Tuberculosis--A Double-Blind, Randomized, Multicenter Study by the Tuberculosis Trials Consortium

Study identification

NCT ID: NCT00140309
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Centers for Disease Control and Prevention; Federal
Enrollment: 350 participants

Conditions and interventions

Conditions

Tuberculosis, Pulmonary

Interventions

moxifloxacin (with isoniazid, rifampin, pyrazinamide) Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 30, 2003
Primary completion: Not listed
Completion: Nov 30, 2005
Last update posted: Mar 18, 2007

2003 – 2005

United States locations

U.S. sites: 18
U.S. states: 12
U.S. cities: 16

Facility	City	State	ZIP	Site status
University of Southern California Medical Center	Los Angeles	California	90033	—
University of California at San Diego	San Diego	California	92103	—
University of California, San Francisco	San Francisco	California	94110	—
Denver Public Health Department	Denver	Colorado	80204	—
Washington DC Veterans Administration Medical Center	Washington D.C.	District of Columbia	20422	—
Emory University School of Medicine	Atlanta	Georgia	30303	—
Hines Vetrans Administration Medical Center	Hines	Illinois	60141	—
Johns Hopkins University	Baltimore	Maryland	21231	—
Boston University Medical Center	Boston	Massachusetts	02118	—
New Jersey School of Medicine	Newark	New Jersey	07107	—
New York University School of Medicine	New York	New York	10016	—
Columbia University	New York	New York	10032	—
Harlem Hospital Center	New York	New York	10037	—
Veterans Administration Tennessee Valley Health Care System	Nashville	Tennessee	37232	—
University of North Texas Health Science Center	Fort Worth	Texas	76104	—
Houston Veterans Administration Medical Center	Houston	Texas	77030	—
Audie L Murphy Memorial Veterans Administration Medical Center	San Antonio	Texas	78284	—
Seattle-King County Health Department	Seattle	Washington	98104	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00140309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 18, 2007 · Synced Jun 26, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00140309 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →